Today is my last day before starting Ibrance (palbociclib). This is the drug the FDA approved on February 3, 2015 -- only five weeks ago! -- that my health insurer has approved as a treatment for me, and for which they are willing to pay $10,000 per month. And it's a pill! I look forward to being much less tied to the chemo chair.
It has the usual side effects, with a special emphasis on neutropenia, the fever accompanying low white blood cell count. I've been fortunate in this long dance with cancer that only a few chemos have had intolerable side effects. I'm hoping that palbo will fall into the majority camp and be both tolerable and effective.
In the meantime I've tried to enjoy my three week chemo break before starting the new stuff.